Skip to main content

Table 3 Differentiating PBL from other Neoplasms by Immunophenotyping

From: Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia

Parameter

PBL

Burkitt

Anaplastic DLBCL

PEL

ALK + DLBCL

PCM/Plasmacytoma

PLASMBLASTIC PCM/Plasmacytoma

Clinical presentation

frequently oral cavity

Often extranodal (jaws and orbits)

Wide variety of presentations

Involves body cavity

Wide variety of presentations

BM (Extramedulary in plasmacytoma)

BM (Extramedulary in plasmacytoma)

Immunocompetency

+/−

++

+++

+/−

+

++

++

Association with HIV

+++

++

++

+++

-

-

-

Association with HHV8

+/− (usually -)

-

-

+

-

-

-

LCA

+/−

+

+

+/−

+/−

+/−

+/−

B-Cell Markers

       

CD20

-

+

+

+/−

-

-

-

CD79a

+/−(usually -)

+

+

-

-

+/− (usually -)

+/− (usually -)

CD138

+

-

-

+

-

+

+

CD56

+/−(usually -)

Rare +

Rare +

Rare +

+/−

Usually +

Usually +

Ki67

High >70 %

High >90 %

High <90 %

High >80 %

High >80 %

Low

High >70 %

Other

BLIMP1+

CD10 +

BCL-6 Usually +

CD30 Usually +

ALK+

Serum M-spike CRAB

Serum M-spike CRAB

  1. CRAB: hypercalcemia, kidney disease, anemia, and bone lytic lesions